BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 24692190)

  • 1. c-MYC-induced genomic instability.
    Kuzyk A; Mai S
    Cold Spring Harb Perspect Med; 2014 Apr; 4(4):a014373. PubMed ID: 24692190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc dependent initiation of genomic instability during neoplastic transformation.
    Taylor C; Jalava A; Mai S
    Curr Top Microbiol Immunol; 1997; 224():201-7. PubMed ID: 9308243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc: linking transformation and genomic instability.
    Prochownik EV
    Curr Mol Med; 2008 Sep; 8(6):446-58. PubMed ID: 18781952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
    Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
    Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc, Genomic Instability and Disease.
    Kuttler F; Mai S
    Genome Dyn; 2006; 1():171-190. PubMed ID: 18724060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of mice and Myc: c-Myc and mammary tumorigenesis.
    Jamerson MH; Johnson MD; Dickson RB
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):27-37. PubMed ID: 15082916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc-induced genomic instability.
    Mai S; Mushinski JF
    J Environ Pathol Toxicol Oncol; 2003; 22(3):179-99. PubMed ID: 14529093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis.
    Lu Y; Wu Y; Feng X; Shen R; Wang JH; Fallahi M; Li W; Yang C; Hankey W; Zhao W; Ganju RK; Li MO; Cleveland JL; Zou X
    J Clin Invest; 2014 Apr; 124(4):1672-84. PubMed ID: 24614102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence.
    Leung JY; Andrechek ER; Cardiff RD; Nevins JR
    Oncogene; 2012 May; 31(20):2545-54. PubMed ID: 21996730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [c-MYC-mediated regulations in colorectal cancer].
    Menssen A
    Pathologe; 2013 Nov; 34 Suppl 2():274-6. PubMed ID: 24196628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
    Fusello A; Horowitz J; Yang-Iott K; Brady BL; Yin B; Rowh MA; Rappaport E; Bassing CH
    Cell Cycle; 2013 Sep; 12(17):2867-75. PubMed ID: 23966158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC and the control of DNA replication.
    Dominguez-Sola D; Gautier J
    Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
    Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
    Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.
    Calvisi DF; Factor VM; Ladu S; Conner EA; Thorgeirsson SS
    Gastroenterology; 2004 May; 126(5):1374-86. PubMed ID: 15131798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic co-operation in beta-cell tumorigenesis.
    Pelengaris S; Khan M
    Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis.
    Anderson PD; McKissic SA; Logan M; Roh M; Franco OE; Wang J; Doubinskaia I; van der Meer R; Hayward SW; Eischen CM; Eltoum IE; Abdulkadir SA
    J Clin Invest; 2012 May; 122(5):1907-19. PubMed ID: 22484818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
    Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
    Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.
    Shen RR; Ferguson DO; Renard M; Hoyer KK; Kim U; Hao X; Alt FW; Roeder RG; Morse HC; Teitell MA
    Blood; 2006 Sep; 108(6):1991-8. PubMed ID: 16728701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.